162 related articles for article (PubMed ID: 23371333)
1. Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival.
Homayounfar K; Bleckmann A; Conradi LC; Sprenger T; Lorf T; Niessner M; Sahlmann CO; Meller J; Liersch T; Ghadimi BM
Int J Colorectal Dis; 2013 Jul; 28(7):1009-17. PubMed ID: 23371333
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
[TBL] [Abstract][Full Text] [Related]
3. Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.
Homayounfar K; Bleckmann A; Conradi LC; Sprenger T; Beissbarth T; Lorf T; Niessner M; Sahlmann CO; Meller J; Becker H; Liersch T; Ghadimi BM
Int J Colorectal Dis; 2012 Oct; 27(10):1359-67. PubMed ID: 22430890
[TBL] [Abstract][Full Text] [Related]
4. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
[TBL] [Abstract][Full Text] [Related]
6. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
[TBL] [Abstract][Full Text] [Related]
7. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
[TBL] [Abstract][Full Text] [Related]
8. Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.
Brandi G; Corbelli J; de Rosa F; Di Girolamo S; Longobardi C; Agostini V; Garajová I; La Rovere S; Ercolani G; Grazi GL; Pinna AD; Biasco G
Langenbecks Arch Surg; 2012 Oct; 397(7):1069-77. PubMed ID: 22711237
[TBL] [Abstract][Full Text] [Related]
9. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
Tsim N; Healey AJ; Frampton AE; Habib NA; Bansi DS; Wasan H; Cleator SJ; Stebbing J; Lowdell CP; Jackson JE; Tait P; Jiao LR
Ann Surg Oncol; 2011 Jul; 18(7):1939-46. PubMed ID: 21298352
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases.
Neeff HP; Drognitz O; Klock A; Illerhaus G; Opitz OG; Hopt UT; Makowiec F
Int J Colorectal Dis; 2012 May; 27(5):635-45. PubMed ID: 22139030
[TBL] [Abstract][Full Text] [Related]
11. [Repeat interventions in metastases].
Seifert JK; Staupendahl D; Junginger T
Chirurg; 1997 Mar; 68(3):247-54. PubMed ID: 9198567
[TBL] [Abstract][Full Text] [Related]
12. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
Viganò L; Procopio F; Cimino MM; Donadon M; Gatti A; Costa G; Del Fabbro D; Torzilli G
Ann Surg Oncol; 2016 Apr; 23(4):1352-60. PubMed ID: 26714946
[TBL] [Abstract][Full Text] [Related]
13. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
14. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis].
Scheele J; Stangl R; Schmidt K; Altendorf-Hofmann A
Chirurg; 1995 Oct; 66(10):965-73. PubMed ID: 8529448
[TBL] [Abstract][Full Text] [Related]
16. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group.
Liersch T; Meller J; Bittrich M; Kulle B; Becker H; Goldenberg DM
Ann Surg Oncol; 2007 Sep; 14(9):2577-90. PubMed ID: 17570017
[TBL] [Abstract][Full Text] [Related]
17. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.
Gonzalez M; Robert JH; Halkic N; Mentha G; Roth A; Perneger T; Ris HB; Gervaz P
World J Surg; 2012 Feb; 36(2):386-91. PubMed ID: 22167262
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
[TBL] [Abstract][Full Text] [Related]
19. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
[TBL] [Abstract][Full Text] [Related]
20. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
